Long‐term peripheral immune cell profiling reveals further targets of oral cladribine in MS

OBJECTIVES: To expand the knowledge about the immunological consequences of cladribine (CLAD), a pulsed immune reconstitution therapy approved for active multiple sclerosis (MS), beyond the known short‐term effects on peripheral immune cell subsets. METHODS: In this study, we characterized depletion...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Clin Transl Neurol
Prif Awduron: Moser, Tobias, Schwenker, Kerstin, Seiberl, Michael, Feige, Julia, Akgün, Katja, Haschke‐Becher, Elisabeth, Ziemssen, Tjalf, Sellner, Johann
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2020
Pynciau:
Research Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7664268/
https://ncbi.nlm.nih.gov/pubmed/33002321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.51206
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg